Real-World Treatment Study of Soliris (Eculizumab)

Trial Identifier:	D7412R00001
Sponsor:	AstraZeneca
NCTID::	NCT06448715
Start Date:	May 2024
Primary Completion Date:	January 2025
Study Completion Date:	January 2025
Condition:	Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
South Korea	Goyang-si, South Korea
South Korea	Seoul, South Korea

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.